BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36472509)

  • 1. Effectiveness of Five Antibiotic Regimens for the Treatment of Intra-Abdominal Infection in Bogotá.
    López GAM; Rodríguez LFC; Fandiño LCS; Lasso AD; Granados JPA; Salazar YID; Pereira KA; Velásquez JP; Luna JAC; Trujillo CHS
    Surg Infect (Larchmt); 2022 Dec; 23(10):933-939. PubMed ID: 36472509
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibiotic Resistance in Community-Acquired Intra-Abdominal Infections: Diabetes Mellitus as a Risk Factor.
    Núñez SA; Lacal V; Núñez J; Serruto G; Zárate MS; Verón MT
    Surg Infect (Larchmt); 2020 Feb; 21(1):62-68. PubMed ID: 31441705
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-effectiveness of ceftolozane/tazobactam plus metronidazole compared with piperacillin/tazobactam as empiric therapy for the treatment of complicated intra-abdominal infections based on the in-vitro surveillance of bacterial isolates in the UK.
    Prabhu V; Foo J; Ahir H; Sarpong E; Merchant S
    J Med Econ; 2017 Aug; 20(8):840-849. PubMed ID: 28532194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-abdominal infections: the role of different classifications on the selection of the best antibiotic treatment.
    Silva-Nunes J; Cardoso T
    BMC Infect Dis; 2019 Nov; 19(1):980. PubMed ID: 31752716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decision-making analysis for selection of antibiotic treatment in intra-abdominal infection using preference measurements.
    Sanabria A
    Surg Infect (Larchmt); 2006 Oct; 7(5):453-62. PubMed ID: 17083311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic Review and Meta-Analysis of the Efficacy of Appropriate Empiric Anti-Enterococcal Therapy for Intra-Abdominal Infection.
    Zhang J; Yu WQ; Chen W; Wei T; Wang CW; Zhang JY; Zhang Y; Liang TB
    Surg Infect (Larchmt); 2021 Mar; 22(2):131-143. PubMed ID: 32471332
    [No Abstract]   [Full Text] [Related]  

  • 7. Prospective, randomized, study of ampicillin-sulbactam versus moxifloxacin monotherapy for the treatment of community-acquired complicated intra-abdominal infections.
    Chen CW; Ming CC; Ma CJ; Shan YS; Yeh YS; Wang JY
    Surg Infect (Larchmt); 2013 Aug; 14(4):389-96. PubMed ID: 23859673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Duration and Empiric Antibiotic Choice of Post-Operative Treatment in Abdominal Sepsis.
    Surat G; Meyer-Sautter P; Rüsch J; Braun-Feldweg J; Germer CT; Lock JF
    Surg Infect (Larchmt); 2022 Jun; 23(5):444-450. PubMed ID: 35532964
    [No Abstract]   [Full Text] [Related]  

  • 9. Time to source control and outcome in community-acquired intra-abdominal infections: The multicentre observational PERICOM study.
    Roger C; Garrigue D; Bouhours G; Dupont H; Bouzat P; Bardon J; Pottecher J; Montravers P; Michelet P; Perbet S; Aymart K; Incagnoli P; Lloret S; Louart B; Harrois A;
    Eur J Anaesthesiol; 2022 Jun; 39(6):540-548. PubMed ID: 35608877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis comparing ceftazidime/avibactam (CAZ-AVI) as empirical treatment comparing to ceftolozane/tazobactam and to meropenem for complicated intra-abdominal infection (cIAI).
    Kongnakorn T; Eckmann C; Bassetti M; Tichy E; Di Virgilio R; Baillon-Plot N; Charbonneau C
    Antimicrob Resist Infect Control; 2019; 8():204. PubMed ID: 31890160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifaceted intervention to optimize antibiotic use for intra-abdominal infections.
    Popovski Z; Mercuri M; Main C; Sne N; Walsh K; Sung M; Rice T; Mertz D
    J Antimicrob Chemother; 2015 Apr; 70(4):1226-9. PubMed ID: 25505004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotics for Patients With a Planned Re-Laparotomy for Intra-Abdominal Infection.
    Hochstetler LJ; Olney WJ; Bishop JM; Warriner ZD; VanHoose JD; Mynatt RP; Ali D; Schadler A; Parli SE
    Surg Infect (Larchmt); 2024 Apr; 25(3):192-198. PubMed ID: 38407831
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of body mass index on treatment of complicated intra-abdominal infections in hospitalized adults: comparison of ertapenem with piperacillin-tazobactam.
    Zakrison TL; Hille DA; Namias N
    Surg Infect (Larchmt); 2012 Feb; 13(1):38-42. PubMed ID: 22217196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic Safety and Effectiveness in Premature Infants With Complicated Intraabdominal Infections.
    Smith MJ; Boutzoukas A; Autmizguine J; Hudak ML; Zinkhan E; Bloom BT; Heresi G; Lavery AP; Courtney SE; Sokol GM; Cotten CM; Bliss JM; Mendley S; Bendel C; Dammann CEL; Weitkamp JH; Saxonhouse MA; Mundakel GT; Debski J; Sharma G; Erinjeri J; Gao J; Benjamin DK; Hornik CP; Smith PB; Cohen-Wolkowiez M;
    Pediatr Infect Dis J; 2021 Jun; 40(6):550-555. PubMed ID: 33902072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of antibiotic resistance, drug target attainment, bacterial pathogenicity and virulence, and antibiotic access and affordability on outcomes in neonatal sepsis: an international microbiology and drug evaluation prospective substudy (BARNARDS).
    Thomson KM; Dyer C; Liu F; Sands K; Portal E; Carvalho MJ; Barrell M; Boostrom I; Dunachie S; Farzana R; Ferreira A; Frayne F; Hassan B; Jones E; Jones L; Mathias J; Milton R; Rees J; Chan GJ; Bekele D; Mahlet A; Basu S; Nandy RK; Saha B; Iregbu K; Modibbo F; Uwaezuoke S; Zahra R; Shirazi H; Syed NU; Mazarati JB; Rucogoza A; Gaju L; Mehtar S; Bulabula ANH; Whitelaw A; van Hasselt JGC; Walsh TR;
    Lancet Infect Dis; 2021 Dec; 21(12):1677-1688. PubMed ID: 34384533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Evaluation of Antibiotic Usage in Complicated Intra-Abdominal Infection after the STOP IT Trial: Did We STOP IT?
    Posillico SE; Young BT; Ladhani HA; Zosa BM; Claridge JA
    Surg Infect (Larchmt); 2019 Apr; 20(3):184-191. PubMed ID: 30676237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged Therapy Is Not Associated with Delayed Identification of Recurrent Intra-Abdominal Infection.
    Dulek A; O'Dell JC; Guidry CA
    Surg Infect (Larchmt); 2022 Nov; 23(9):796-800. PubMed ID: 36251958
    [No Abstract]   [Full Text] [Related]  

  • 18. Cefoperazone-sulbactam for treatment of intra-abdominal infections: results from a randomized, parallel group study in India.
    Chandra A; Dhar P; Dharap S; Goel A; Gupta R; Hardikar JV; Kapoor VK; Mathur AK; Modi P; Narwaria M; Ramesh MK; Ramesh H; Sastry RA; Shah S; Virk S; Sudheer OV; Sreevathsa MR; Varshney S; Kochhar P; Somasundaram S; Desai C; Schou M
    Surg Infect (Larchmt); 2008 Jun; 9(3):367-76. PubMed ID: 18570578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of excessive duration of antibiotic therapy for intra-abdominal infection with subsequent extra-abdominal infection and death: a study of 2,552 consecutive infections.
    Riccio LM; Popovsky KA; Hranjec T; Politano AD; Rosenberger LH; Tura KC; Sawyer RG
    Surg Infect (Larchmt); 2014 Aug; 15(4):417-24. PubMed ID: 24824591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic and Duration of Perioperative Prophylaxis Predicts Surgical Site Infection in Head and Neck Surgery.
    Langerman A; Thisted R; Hohmann S; Howell M
    Otolaryngol Head Neck Surg; 2016 Jun; 154(6):1054-63. PubMed ID: 26932957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.